Ou, Wen-Bin
Brigham and Women's Hospital · Zhejiang Sci-Tech University · Harvard University
4 papers on CoChatORCID 0000-0002-6311-9442
Most cited papers
- Verified
Knockdown of creatine kinase B inhibits ovarian cancer progression by decreasing glycolysis
Li, X.-H., Chen, X.-J., Ou, W.-B., Zhang, Q., Lv, Z.-R., Zhan, Y., Ma, L., Huang, T., Yan, Y.-B., & Zhou, H.-M. (2013) · The International Journal of Biochemistry & Cell Biology
Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer
Cited by 74
- Verified
Aberrant AKT activation drives well-differentiated liposarcoma
Gutierrez, A., Snyder, E. L., Marino-Enriquez, A., Zhang, Y.-X., Sioletic, S., Kozakewich, E., Grebliunaite, R., Ou, W.-B., Sicinska, E., Raut, C. P., et al. (2011) · Proceedings of the National Academy of Sciences
Sarcoma Diagnosis and TreatmentPI3K/AKT/mTOR signaling in cancer
Cited by 58
- Verified
Targeting SALL4 by entinostat in lung cancer
Yong, K. J., Li, A., Ou, W.-B., Hong, C. K. Y., Zhao, W., Wang, F., Tatetsu, H., Yan, B., Qi, L., Fletcher, J. A., et al. (2016) · Oncotarget
Histone Deacetylase Inhibitors ResearchLung Cancer Research Studies
Cited by 41
- Verified
Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3
Yang, P., Chen, W., Li, X., Eilers, G., He, Q., Liu, L., Wu, Y., Wu, Y., Yu, W., Fletcher, J. A., et al. (2016) · Oncotarget
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free